American Well Corp
AMWL7.250USD
+0.240+3.42%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
112.88MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über American Well Corp Unternehmen
American Well Corporation operates a hybrid care delivery enablement platform in the United States and globally, connecting providers, payers, patients and innovators. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke and acute psychiatry evaluations to virtual nursing and e-sitting. For health plans, employers and government entities, its enterprise platform enables a broad set of use cases, including primary, urgent, mental health, specialty, and chronic care. Its virtual primary care solution offers a primary care navigation hub. It offers new tailored healthcare solutions for government clients that provide care options to meet the diverse needs of government healthcare systems, personnel, and their families.
Unternehmensinformationen
BörsenkürzelAMWL
Name des UnternehmensAmerican Well Corp
IPO-datumSep 17, 2020
CEOMr. Ido Schoenberg, M.D.
Anzahl der mitarbeiter877
WertpapierartOrdinary Share
GeschäftsjahresendeSep 17
Addresse75 State Street
StadtBOSTON
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl02109
Telefon16172053500
Websitehttps://business.amwell.com/
BörsenkürzelAMWL
IPO-datumSep 17, 2020
CEOMr. Ido Schoenberg, M.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Roy Schoenberg, M.D.
Dr. Roy Schoenberg, M.D.
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
108.30K
--
Mr. Ido Schoenberg, M.D.
Mr. Ido Schoenberg, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
64.25K
-6.64%
Dr. Peter L. Slavin, M.D.
Dr. Peter L. Slavin, M.D.
Independent Director
Independent Director
44.47K
+88.60%
Mr. Derek Ross
Mr. Derek Ross
Independent Director
Independent Director
29.49K
+242.86%
Ms. Deborah C. Jackson
Ms. Deborah C. Jackson
Independent Director
Independent Director
26.14K
+398.30%
Mr. Dmitry (Dan) Zamansky
Mr. Dmitry (Dan) Zamansky
Chief Product and Technology Officer
Chief Product and Technology Officer
2.47K
--
Dr. Delos Marshall (Toby) Cosgrove, M.D.
Dr. Delos Marshall (Toby) Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Mark Hirschhorn
Mr. Mark Hirschhorn
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
--
--
Ms. Phyllis I. Gotlib
Ms. Phyllis I. Gotlib
President, American Well International
President, American Well International
--
--
Ms. Rivka R. (Ricky) Goldwasser
Ms. Rivka R. (Ricky) Goldwasser
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Roy Schoenberg, M.D.
Dr. Roy Schoenberg, M.D.
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
108.30K
--
Mr. Ido Schoenberg, M.D.
Mr. Ido Schoenberg, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
64.25K
-6.64%
Dr. Peter L. Slavin, M.D.
Dr. Peter L. Slavin, M.D.
Independent Director
Independent Director
44.47K
+88.60%
Mr. Derek Ross
Mr. Derek Ross
Independent Director
Independent Director
29.49K
+242.86%
Ms. Deborah C. Jackson
Ms. Deborah C. Jackson
Independent Director
Independent Director
26.14K
+398.30%
Mr. Dmitry (Dan) Zamansky
Mr. Dmitry (Dan) Zamansky
Chief Product and Technology Officer
Chief Product and Technology Officer
2.47K
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Platform Subscription
32.21M
48.20%
Visits
26.63M
39.84%
Other
8.00M
11.96%
Nach RegionUSD
Name
Umsatz
Anteil
United States
66.83M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Platform Subscription
32.21M
48.20%
Visits
26.63M
39.84%
Other
8.00M
11.96%
Aktionärsstatistik
Aktualisiert: Tue, Jun 17
Aktualisiert: Tue, Jun 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Senvest Management, LLC
9.24%
Morgan Stanley & Co. LLC
8.65%
Caledonia (Private) Investments Pty Limited
5.72%
The Vanguard Group, Inc.
4.46%
Alerce Investment Management, L.P.
3.70%
Other
68.23%
Aktionäre
Aktionäre
Anteil
Senvest Management, LLC
9.24%
Morgan Stanley & Co. LLC
8.65%
Caledonia (Private) Investments Pty Limited
5.72%
The Vanguard Group, Inc.
4.46%
Alerce Investment Management, L.P.
3.70%
Other
68.23%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
15.81%
Hedge Fund
12.41%
Research Firm
9.79%
Individual Investor
4.83%
Investment Advisor/Hedge Fund
4.75%
Private Equity
3.70%
Corporation
0.55%
Pension Fund
0.23%
Sovereign Wealth Fund
0.20%
Other
47.74%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
329
7.41M
52.30%
-1.63M
2025Q1
349
7.29M
51.54%
-1.83M
2024Q4
358
7.65M
54.80%
-1.30M
2024Q3
371
7.45M
54.59%
-1.39M
2024Q2
383
8.06M
60.42%
-1.29M
2024Q1
405
8.42M
64.02%
-956.28K
2023Q4
418
8.05M
63.03%
-798.02K
2023Q3
431
8.26M
67.90%
-1.19M
2023Q2
440
8.42M
67.58%
-997.87K
2023Q1
473
8.34M
67.92%
-1.29M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Senvest Management, LLC
1.31M
9.24%
+7.74K
+0.60%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.23M
8.65%
+4.20K
+0.34%
Mar 31, 2025
Caledonia (Private) Investments Pty Limited
810.27K
5.72%
-31.07K
-3.69%
Mar 31, 2025
The Vanguard Group, Inc.
632.14K
4.46%
+11.29K
+1.82%
Mar 31, 2025
Alerce Investment Management, L.P.
523.78K
3.7%
--
--
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
205.61K
1.45%
-25.34K
-10.97%
Mar 31, 2025
Millennium Management LLC
199.01K
1.41%
+30.69K
+18.23%
Mar 31, 2025
Acadian Asset Management LLC
188.22K
1.33%
+30.67K
+19.47%
Mar 31, 2025
Renaissance Technologies LLC
174.92K
1.24%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
159.20K
1.12%
+11.28K
+7.62%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
Invesco RAFI US 1500 Small-Mid ETF
0.01%
JPMorgan BetaBuilders US Small Cap Equity ETF
0%
iShares Russell 2000 ETF
0%
Fidelity MSCI Health Care Index ETF
0%
iShares Russell 3000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Morningstar Small-Cap Value ETF
0%
Mehr Anzeigen
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.01%
JPMorgan BetaBuilders US Small Cap Equity ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
Fidelity MSCI Health Care Index ETF
Anteil0%
iShares Russell 3000 ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Global X Russell 2000 Covered Call ETF
Anteil0%
ProShares Hedge Replication ETF
Anteil0%
iShares Russell 2000 Value ETF
Anteil0%
iShares Morningstar Small-Cap Value ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Jun 28, 2024
Merger
20<1
Jun 28, 2024
Merger
20<1
Jun 28, 2024
Merger
20<1
Jun 28, 2024
Merger
20<1
Datum
Art
Verhältnis
Jun 28, 2024
Merger
20<1
Jun 28, 2024
Merger
20<1
Jun 28, 2024
Merger
20<1
Jun 28, 2024
Merger
20<1
